508 filings
Page 10 of 26
CORRESP
zz8s7z9 stuzxscg502m
2 Dec 20
Correspondence with SEC
12:00am
8-K
5zwnf 5cwrsdu6
24 Nov 20
Opgen, Inc. Announces $10 Million Private Placement Priced at the Market
4:57pm
424B3
vb3qb bl57spj
13 Nov 20
Prospectus supplement
4:55pm
8-K
k1404xvtlg62ea
13 Nov 20
First commercial orders completed, assay design based on proprietary ARESdb to comprehensively cover antibiotic resistance markers
4:52pm
8-K
4xs obm0dgl5
12 Nov 20
OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update
6:15am
8-K
6dpu3z1rb24g4jy67v92
2 Nov 20
Departure of Directors or Certain Officers
4:33pm
8-K
5fxl6l1 dlfh3
15 Oct 20
Results of Operations and Financial Condition
4:20pm
8-K
r3ae2ho1ev
2 Oct 20
Departure of Directors or Certain Officers
5:19pm
DEFA14A
zriirbyn0
18 Sep 20
Additional proxy soliciting materials
5:05pm
424B5
pgv1sg3gh3
4 Sep 20
Prospectus supplement for primary offering
4:15pm
8-K
l7b3p5vdb cx9j8x
20 Aug 20
Regulation FD Disclosure
4:34pm
DEFA14A
ksbpwz
20 Aug 20
Additional proxy soliciting materials
4:09pm
S-8
9d2x0ar0ctep1wzkkim
14 Aug 20
Registration of securities for employees
5:00pm
8-K/A
jamf h3o6zh
12 Aug 20
Other Events
5:23pm
8-K
nxy ugc9o
12 Aug 20
OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update
4:24pm
8-K
chyxz9 qh5ndrcfctqgb
11 Aug 20
Departure of Directors or Certain Officers
4:10pm